Procter & Gamble Health Ltd

₹5,405.6▼ -0.16%28 Sept

📊 Stock Analysis

Market Data

Market Cap₹8,972.96 Cr.

52W High₹6,955

Current Price₹5,405.6

52W Low₹4,699.7

Down from 52W High22.3 %

Face Value₹10

Performance

ROCE91.93 %

ROE68.04 %

EPS (TTM)₹57.92

EPS Prev Qtr₹56.99

EPS Last Year₹53.34

EBITDA Qtr₹93.58 Cr.

Book Value₹316

Financial Health

Debt/Equity0.02

Debt/Profit0.03

Total Assets₹841.35 Cr.

Dividend Yield7.68 %

Promoter Holding51.82 %

Earning Power52.5 %

Valuation

Stock P/E25.14

Industry P/E33.81

Price to Book17.11

Price to Sales6.26

Graham Number₹1,236.22

Key Metrics

Dividend/Share

₹210

Face Value

₹10

About Procter & Gamble Health Ltd

Healthcare · Pharmaceuticals

Procter & Gamble Health Ltd is listed on NSE in the Healthcare / Pharmaceuticals sector. Face value ₹10. Market cap ₹8,972.96 Cr.

Price Chart

Peer Comparison

Name	CMP	P/E	Market Cap	Div Yield	NP Qtr	Qtr Profit Var%	Sales Qtr	Qtr Sales Var%	ROCE%	Debt/Eq
Sun Pharmaceutical Industries Ltd	-	36.51	₹4,41,477.63 Cr	0.87%	₹12,172.7 Cr	-	₹59,910.52 Cr	-	18.72%	0.05
Divis Laboratories Ltd	-	86.48	₹2,53,031.38 Cr	0.31%	₹2,925 Cr	-	₹11,230 Cr	-	23.04%	0
Torrent Pharmaceuticals Ltd	-	77.67	₹1,85,216.32 Cr	0.78%	₹2,156 Cr	-	₹15,723 Cr	-	15.1%	1.76
Zydus Lifesciences Ltd	-	27.01	₹1,20,897.46 Cr	0.08%	₹4,492.2 Cr	-	₹28,591.7 Cr	-	16.76%	0.43
Cipla Ltd	-	33.28	₹1,12,201.64 Cr	0.94%	₹3,364.84 Cr	-	₹28,324.4 Cr	-	13.24%	0.01
Laurus Labs Ltd	-	99.31	₹1,08,698.22 Cr	0.06%	₹1,090.76 Cr	-	₹7,269.64 Cr	-	20.79%	0.45
Dr Reddys Laboratories Ltd	-	31.6	₹1,02,039.12 Cr	0.65%	₹3,183.3 Cr	-	₹33,227.9 Cr	-	10.05%	0.17
Mankind Pharma Ltd	-	49.29	₹1,00,752.43 Cr	0.04%	₹2,067.57 Cr	-	₹14,737.88 Cr	-	13.95%	0.38
Aurobindo Pharma Ltd	-	26.56	₹97,814.24 Cr	0.24%	₹3,710.8 Cr	-	₹34,935.29 Cr	-	12.75%	0.2
Lupin Ltd	-	16.64	₹94,274.49 Cr	0.87%	₹5,550.99 Cr	-	₹29,966.58 Cr	-	27.95%	0.26
Glenmark Pharmaceuticals Ltd	-	36.67	₹65,922.11 Cr	0.11%	₹1,797.81 Cr	-	₹17,736.56 Cr	-	24.78%	0.25
Alkem Laboratories Ltd	-	28.65	₹61,804.34 Cr	1.03%	₹2,206.3 Cr	-	₹15,081.28 Cr	-	19.75%	0.12
Biocon Ltd	-	110.29	₹61,113.53 Cr	0.13%	₹416.4 Cr	-	₹17,321.1 Cr	-	2.87%	0.43
Abbott India Ltd	-	35.22	₹56,860.69 Cr	1.78%	₹1,614.68 Cr	-	₹7,004.38 Cr	-	45.73%	0
Glaxosmithkline Pharmaceuticals Ltd	-	46.73	₹49,091.33 Cr	1.97%	₹1,068.15 Cr	-	₹3,954.94 Cr	-	64.07%	0
Ipca Laboratories Ltd	-	36.13	₹48,712.48 Cr	0.31%	₹1,379.76 Cr	-	₹10,125.58 Cr	-	21.48%	0.09
Anthem Biosciences Ltd	-	83.03	₹47,949.68 Cr	0.23%	₹575.95 Cr	-	₹2,002.34 Cr	-	25.5%	0.02
Gland Pharma Ltd	-	42.26	₹47,764.08 Cr	0.69%	₹1,128.8 Cr	-	₹6,725.3 Cr	-	15.21%	0.02
Ajanta Pharma Ltd	-	38.87	₹44,109.77 Cr	0.79%	₹1,134.88 Cr	-	₹5,776.17 Cr	-	31.81%	0.05
J B Chemicals & Pharmaceuticals Ltd	-	53.3	₹38,730.77 Cr	0.39%	₹709.46 Cr	-	₹4,147.79 Cr	-	23.03%	0

Quarterly Results

	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Sales	324.92	373.86	370.45	363.71
↳ QoQ Growth	-	+15.1%	-0.9%	-1.8%
Expenses	210.73	269.3	241.03	270.13
Operating Profit	114.19	104.56	129.42	93.58
OPM %	35.14%	27.97%	34.94%	25.73%
Other Income	4.95	4.36	4	3.88
Interest	0.12	0.1	0.21	0.14
Depreciation	6.08	5.9	6.17	6.02
EBITDA	120.27	110.46	135.59	99.6
EBITDA Margin %	37.02%	29.55%	36.6%	27.38%
Profit Before Tax	119.02	108.82	133.21	129.12
Tax %	25.61%	28.7%	28.98%	25.53%
Net Profit	88.54	77.59	94.6	96.15
↳ QoQ Growth	-	-12.4%	+21.9%	+1.6%
EPS	53.34	46.74	56.99	57.92

Balance Sheet

	Mar 2025	Mar 2026
Equity Capital	16.6	16.6
Reserves	520.36	507.95
Borrowings	0	9.29
Other Liabilities	257.24	307.51
Total Liabilities	794.2	841.35
Fixed Assets	111.74	101.75
CWIP	10.96	13.59
Investments	4.37	0
Other Assets	667.13	726.01
Total Assets	794.2	841.35

Cash Flows

	Mar 2025
Cash from Operating Activity	168.69
Cash from Investing Activity	9.59
Cash from Financing Activity	-234.74
Net Cash Flow	-56.46

Shareholding Pattern

	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Promoters %	51.82%	51.82%	51.82%	51.82%
FIIs %	7.24%	6.97%	6.2%	6.33%
DIIs %	13.91%	13.84%	13.67%	12.44%
Public %	22.15%	22.43%	23.17%	23.56%
No. of Shareholders	50,006	49,302	50,883	49,056